Changes in components of the contact activation following circulation of the blood within the heart lung machine.
D000990:Antithrombin III / Q000378:metabolism; D001769:Blood / Q000378:metabolism*; D005174:Factor XII / Q000037:antagonists & inhibitors; D015956:Factor XIIa; D006355:Heart-Lung Machine / Q000009:adverse effects*; D006801:Humans; D066298:In Vitro Techniques; D007610:Kallikreins / Q000037:antagonists & inhibitors / Q000097:blood; D007705:Kinins / Q000097:blood; D011288:Prekallikrein / Q000097:blood; D015842:Serine Proteinase Inhibitors
D007705:Kinins; D015842:Serine Proteinase Inhibitors; D000990:Antithrombin III; D005174:Factor XII; D011288:Prekallikrein; D007610:Kallikreins; D015956:Factor XIIa